Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukaemia

被引:0
作者
Perz, JB [1 ]
Sanz, J [1 ]
Ghorashian, S [1 ]
Chaidos, A [1 ]
Kaeda, J [1 ]
Szydlo, RM [1 ]
Marin, DC [1 ]
Olavarria, E [1 ]
Apperley, JF [1 ]
机构
[1] Hammersmith Hosp, London, England
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S227 / S227
页数:1
相关论文
共 50 条
[21]   ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REDUCED-INTENSITY CONDITIONING IN CHRONIC MYELOID LEUKAEMIA [J].
Morozova, E., V ;
Vlasova, Y., I ;
Barabanshikova, M., V ;
Afanaseva, K. S. ;
Iurovskaia, K. S. ;
Gindina, T. L. ;
Barchatov, I. M. ;
Alyanskiy, A. L. ;
Bakin, E. A. ;
Bondarenko, S. N. ;
Moiseev, I. S. ;
Zubarovskaya, L. S. ;
Afanasyev, B., V .
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (04) :386-402
[22]   Remission of ulcerative colitis followed by allogeneic blood stem cell transplantation for chronic myeloid leukaemia [J].
Kim, C. S. ;
Kim, I. ;
Kim, H. G. ;
Lee, H. B. ;
Kim, J. M. ;
Lim, J. H. ;
Yi, H. G. ;
Kim, J. S. ;
Park, H. ;
Lee, M. H. .
BONE MARROW TRANSPLANTATION, 2007, 39 :S315-S316
[23]   Imatinib mesylate therapy in patients with chronic myeloid leukaemia previously treated with autologous stem cell transplantation [J].
Cortés, M ;
Sureda, A ;
Martino, R ;
Aventin, A ;
Nomdedeu, J ;
Briones, J ;
Valcárcel, D ;
Brunet, S ;
Sierra, J .
BONE MARROW TRANSPLANTATION, 2004, 33 :S151-S151
[24]   Imatinib Mesylate Versus Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Chronic Myeloid Leukemia In Chronic Phase [J].
Liu Xiaoli ;
Gao, Guanlun ;
Zhou, Xuan ;
Xu, Na ;
Xiao, Yajuan ;
Cao, Rui ;
Yin, Changxin ;
Zhou, Hongsheng ;
Wei, Yongqiang ;
Zhang, Yu ;
Xu, Dan ;
Xu, Bing ;
Feng, Ru ;
Liu, Qifa ;
Sun, Jing ;
Meng, Fanyi .
BLOOD, 2013, 122 (21)
[25]   Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia [J].
Pavlu, Jiri ;
Apperley, Jane F. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (01) :43-51
[26]   Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia [J].
Jiří Pavlů ;
Jane F. Apperley .
Current Hematologic Malignancy Reports, 2013, 8 :43-51
[27]   Acute myeloid leukaemia (AML) and allogeneic haematopoietic stem cell transplantation [J].
Nachbaur, D. .
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) :104-107
[28]   Acute myeloid leukaemia (AML) and allogeneic haematopoietic stem cell transplantation [J].
David Nachbaur .
memo - Magazine of European Medical Oncology, 2009, 2 (2) :104-107
[29]   Outcome of allogeneic stem cell transplantation in patients with chronic myeloid leukaemia treated with second generation tyrosine kinases inhibitors after imatinib failure [J].
Palandri, F. ;
Breccia, M. ;
Iori, A. P. ;
Bonifazi, F. ;
Latagliata, R. ;
Colaci, E. ;
Torelli, G. F. ;
Castagnetti, F. ;
Valle, V. ;
Usai, S. ;
Martinelli, G. ;
Dell'Agnola, C. ;
Cingarlini, S. ;
Rosti, G. ;
Baccarani, M. ;
Alimena, G. .
BONE MARROW TRANSPLANTATION, 2009, 43 :S261-S261
[30]   One year follow-up of chronic myeloid leukaemia patients, who received imatinib prior to myeloablative allogeneic stem cell transplantation [J].
Zaucha, JM ;
Prejzner, W ;
Giebel, S ;
Szatkowski, D ;
Balon, J ;
Wojnar, J ;
Kruzel, T ;
Kalwak, K ;
Holowiecki, J ;
Hellmann, A .
BONE MARROW TRANSPLANTATION, 2005, 35 :S237-S238